Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study. (January 2019) - Hochmair, M.; Cufer, T.; Morabito, A.; Hao, D.; Ta Yang, C.; Soo, R.; Yang, J.; Gucalp, R.; Halmos, B.; Wang, L.; Golembesky, A.; Märten, A.; et al.